Donga Socio Holdings (000640) fair value: what the stock is really worth
As of Oct 19, 2026: fair value (intrinsic value) of Donga Socio Holdings stock KRW 240,231, price KRW 93,900, upside +155.8%, quality 58 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range 70,497 KRW – 119,396 KRW · fair‑value band 180,173 KRW – 300,289 KRW · the 93,900 KRW price screens below the 240,231 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Donga Socio in your weekly email
Every Wednesday you see whether Donga Socio is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments.
Show moreShow less
The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS. It also provides medical devices and equipment; healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and cosmetics; health functional food; contract development and manufacturing organization for biosimilar and pharmaceutical products, and oligonucleotide therapeutics; functional sports drinks under the POCARI SWEAT brand; logistics and fulfillment services; glass bottles, PET bottles, aluminum and plastic caps, and paper packaging boxes; mineral and carbonated water, and mixed drinks; and IT and construction services.
In addition, the company is involved in engineering; cargo, courier, and automobile transport arrangement; transportation warehousing and leasing; real estate development; agricultural product distribution; management consulting; business management; and architectural, electric work, fire protection, and housing contracting services.
Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
Stock analysis
Donga Socio Holdings (000640) currently trades at 93,900 KRW, while our model-based Fair Value estimate is 240,231 KRW, implying the stock looks roughly 60.9% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 364,352 KRW per share, and 24 of the 26 models we run sit above the 93,900 KRW price.
Bear case: the Earnings-Based group reads lowest at 94,397 KRW, and 2 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 180,173 KRW (bear) to 300,289 KRW (bull), the price of 93,900 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Donga Socio Holdings reported revenue of 1.4T KRW in FY2025 versus 882B KRW in FY2021, a compound +12.8%/yr. Reported net income was 90.9B KRW in FY2025, compounding +10.8%/yr from FY2021.
Key figures
Market cap 622B KRW (≈ $468M) Small · P/S ratio 0.40 · Dividend yield 1.8% · Net margin 5.6% · Return on equity 7.3% · Return on assets (EBIT) 3.7% · Operating margin 9.5% · Revenue (TTM) 1.5T KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 20% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −24% fair-value upside, at 156%, 000640 screens cheaper than that median.
Fair Value models
Bear180,173 KRWFair Value 240,231 KRWBull300,289 KRW
Price 93,900 KRW · Upside +155.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.88/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+7.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.8%
Start year 2020 (pandemic). Over 10 years: +7.3% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +13.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+11.5%
Dividend (yield on the price)1.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.7.3% vs −2.0%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Rate on operating basis: 2025 sits 52% above its own trend.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−10.5%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −12.4% a year for the price and +5.1% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 577 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score58 · Above median
Fair Value upside+155.3% · Top 25%
Profitability
Return on equity (12 months)7.3% · Above median
Return on assets4.4% · Above median
Net margin (12 months)5.6% · Below median
Operating margin (12 months)9.5% · Below median
Growth and dividend
Revenue growth (quarter YoY)18.9% · Top 25%
Dividend yield (12 months)1.8% · Above median
Balance sheet
Debt / equity0.14× · Above median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Donga Socio Holdings (000640) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of 240,231 KRW versus a price of 93,900 KRW, about +156% upside (undervalued).
What is the fair value of 000640?
Our model-based fair value for Donga Socio Holdings is 240,231 KRW (as of Oct 2, 2026), built from audited fundamentals. The current price: 93,900 KRW.
What is the quality score of 000640?
Donga Socio Holdings has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Donga Socio Holdings (000640)?
Our model-based price target is the fair value of 240,231 KRW (as of Oct 2, 2026) from 26 valuation models. Cautious scenario 180,173 KRW, optimistic scenario 300,289 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Donga Socio Holdings stock forecast for 2026?
Our models put fair value at 240,231 KRW, about +156% upside versus a price of 93,900 KRW (undervalued). Cautious scenario 180,173 KRW, optimistic scenario 300,289 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Donga Socio Holdings (000640)?
Donga Socio Holdings reported trailing-twelve-month revenue of about 1.5T KRW (latest available figure, as of Oct 2, 2026).
Does Donga Socio Holdings pay a dividend?
Donga Socio Holdings currently shows a dividend yield of 1.81% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Donga Socio Holdings (000640)?
For today's price to be fair in a discounted-cash-flow model, Donga Socio Holdings would have to grow free cash flow by -10.5 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.8 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of 000640 use?
Our models discount Donga Socio Holdings at 10.2 %: a base by market capitalisation (small), damped by beta 0.10, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Donga Socio Holdings that is -10.5 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has Donga Socio Holdings (000640) delivered so far?
Over the past 5 years revenue at Donga Socio Holdings grew +12.8 % a year. The price currently implies -10.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Donga Socio Holdings (000640) growing?
The median revenue growth in the sector is +5.6 % a year. That is the yardstick for the growth priced into Donga Socio Holdings (-10.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Donga Socio Holdings (000640)?
The free-cash-flow yield on the price is 27.11 %: that much free cash flow Donga Socio Holdings produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Donga Socio Holdings (000640)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Donga Socio Holdings it is 240,231 KRW per share (as of Oct 2, 2026), against a price of 93,900 KRW. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Donga Socio Holdings stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 000640 trades below its calculated fair value: price 93,900 KRW, fair value 240,231 KRW, a gap of about +156% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 000640?
No. The price is what the market pays today (93,900 KRW); the fair value is what the company's own numbers justify (240,231 KRW). For Donga Socio Holdings the two are 146,331 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Donga Socio Holdings worth?
The market values Donga Socio Holdings at about 622B KRW (market capitalisation, as of Oct 2, 2026). Per share that is 93,900 KRW; our models calculate a fair value of 240,231 KRW per share.
What do the bullish and bearish scenarios say about 000640?
Our models span a range for Donga Socio Holdings: cautious scenario 180,173 KRW, base 240,231 KRW, optimistic 300,289 KRW per share (as of Oct 2, 2026, price 93,900 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Donga Socio Holdings (000640)?
Balance-sheet figures for Donga Socio Holdings (as of Oct 2, 2026): return on equity 7.3%, debt of 0.14 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 000640 from its 52-week high?
Donga Socio Holdings trades at 93,900 KRW, about 20% below its 52-week high of 118,083 KRW and 24% above the low of 75,800 KRW (as of Oct 19, 2026). Distance from the high says nothing about value: that is what the fair value of 240,231 KRW is for.
Which stocks are comparable to Donga Socio Holdings?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Donga Socio Holdings stock attractive at the current price?
The data as of Oct 2, 2026: price 93,900 KRW, calculated fair value 240,231 KRW (+156%), Quality Score 58/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 000640 calculated?
We run Donga Socio Holdings through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 240,231 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Donga Socio Holdings currently trades 61 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Donga Socio Holdings (000640)?
The closing price on Oct 19, 2026 was 93,900 KRW. Our model-based fair value is 240,231 KRW, about +156% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Donga Socio Holdings right now?
The price is below even our cautious bear case (180,173 KRW). The market is more pessimistic than our downside scenario. Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Donga Socio Holdings
How large is the market capitalisation of Donga Socio Holdings (000640)?
The market capitalisation of Donga Socio Holdings is 622B KRW (≈ $468M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Donga Socio Holdings (000640)?
The price-to-sales ratio of Donga Socio Holdings is 0.40 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Donga Socio Holdings (000640)?
The dividend yield of Donga Socio Holdings is 1.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Donga Socio Holdings (000640)?
The net margin of Donga Socio Holdings is 5.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Donga Socio Holdings (000640)?
The return on equity (ROE) of Donga Socio Holdings is 7.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Donga Socio Holdings (000640)?
On an EBIT basis the return on assets of Donga Socio Holdings is 3.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Donga Socio Holdings (000640)?
The operating margin of Donga Socio Holdings is 9.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Donga Socio Holdings (000640)?
Revenue at Donga Socio Holdings is growing +18.9% versus a year earlier (3y avg +12.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Donga Socio Holdings (000640)?
Earnings per share at Donga Socio Holdings are growing −23.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Donga Socio Holdings (000640) carry?
The net debt of Donga Socio Holdings is 436B KRW (fiscal year 2025, ≈ 2.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Donga Socio Holdings in the live analysis
One click puts Donga Socio Holdings on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Some data
Oct 2, 2026